NewsBenzingaBTIG Reiterates Buy on Walmart, Maintains $140 Price Target BTIG Reiterates Buy on Walmart, Maintains $140 Price Target Benzinga 2026.11.20 12:26 (GMT+0) Open on Benzinga Other news Keybanc Downgrades BILL Holdings to Sector Weight William Blair Upgrades Pyxis Oncology to Outperform Procter & Gamble Plans up to 30% Supply Job Cuts by 2030, Aims for $10 Billion in Cost Savings Mark Cuban Says Healthcare Economics Run On ‘Contractual Terrorism’: ‘Even the Biggest Companies Get Ripped Off’ Hewlett Packard Enterprise Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Vanda Pharmaceuticals Settles Patent Infringement Litigation Against MSN Pharmaceuticals With Royalty-Free License For Generic Tasimelteon, Effective From Q1 2040
Mark Cuban Says Healthcare Economics Run On ‘Contractual Terrorism’: ‘Even the Biggest Companies Get Ripped Off’
Hewlett Packard Enterprise Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Vanda Pharmaceuticals Settles Patent Infringement Litigation Against MSN Pharmaceuticals With Royalty-Free License For Generic Tasimelteon, Effective From Q1 2040